Our thinking Podcasts Private Conversations

Interview with Kate Bingham: VC mindset to fixing global problems


We interviewed Kate Bingham, former Chair of the UK Vaccine Taskforce, and Managing Partner of SV Health Investors. During the interview we discussed:

• Kate's role as Chair of the UK Vaccine Taskforce and how she and her team initiated the program,

• The challenges they faced,

• How they delivered on vaccine procurement.

• How a VC mindset can help to fix global problems such as pandemics.

• SV's history and funds (including dementia and biotech).

• Impact funds – challenges and opportunities.

We are particularly grateful to Kate for joining this week's call and want to thank her for her contribution to saving millions of lives across the world.

Kate Bingham is the former Chair of the UK Vaccine Taskforce. As Chair of the Vaccine Taskforce in 2020 she led a team of world-class experts from across industry, science, academia, funding, regulators, logistics and government with the shared purposed of finding and manufacturing COVID-19 vaccine/s. The Vaccine Taskforce helped place the UK at the leading edge of the international effort to fight the pandemic through the development of clinically safe and effective vaccines.

Kate has worked in the biotech and life sciences sectors for 30 years and is Managing Partner at life sciences venture capital firm SV Health Investors and a board member of the Francis Crick Institute. Her investments have led to the launch of six drugs for the treatment of patients with inflammatory and autoimmune disease and cancer.

Kate is responsible for SV’s biotech investments and activities and serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She played an active role in setting up the Dementia Discovery Fund (DDF) and supports the International Biotechnology Trust listed on the LSE.

She won the Lifetime Achievement Award, presented by the BioIndustry Association UK in January 2017 and has a first class degree in Biochemistry from the University of Oxford and an MBA from Harvard Business School (Baker Scholar).

©  Zoë Devlin 2020/2021

Relevant links:

MJ Hudson services - Venture capital law

Kate Bingham's LinkedIn - Click here

Kate Bingham's Wikipedia - Click here

SV Health Investors website - Click here

MJ Hudson quick read - Back to school for venture investing? VC in the post-Covid environment

MJ Hudson quick read - Investing in biotech

MJ Hudson quick read - 10 VC facts: past, present and future

Featured song - Mark Ronson - Uptown Funk

  • Topics
  • biotech
  • covid
  • covid-19
  • impact funds
  • Kate Bingham
  • SV Health Investors
  • taskforce
  • vaccine
  • VC
  • venture capital
Get email alerts for tailored content on your favourite topics
Sign up to email alerts
Eamon Devlin and Lauren Burton interview Antoine Drean, Founder & Chairman of Triago, to discuss secondaries, M&A, technology and more.
Lindsey McMurray, Co-Founder & Managing Partner, Pollen Street Capital discusses sustainable fundraising, social mobility and more.

Browser Compatibility Notice

Welcome to MJ Hudson. Please note, this website will not function as intended on Internet Explorer.

For the full experience, we recommended viewing this website on a modern browser, such as Edge, Google Chrome or Mozilla Firefox.

Share this page using the options below